QITOLBY
RegisteredWord Mark
•
Ownership
BA
Owner Name
Type: Organization / Aktiengesellschaft (Ag)
Address
Kaiser-wilhelm-allee
Leverkusen, 51373
Germany
Critical Dates
First Use Date
Not filed yet
Filing Date
Feb 27, 2025
Registration Date
Dec 30, 2025
Mark Descriptions
Goods
Class 5
Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases; Pharmaceutical preparations for the treatment and prevention of inflammation; Pharmaceutical preparations for the treatment of cancer
Mark Elements
Text Mark
QITOLBY
Category
Trademark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO websiteTrademark Timeline
Filing Date
Publication Date
Registration Date
USPTO Records
| Title | Date | Category | Source | Pages | Format | Actions |
|---|---|---|---|---|---|---|
AI AssessmentCached Mar 12, 2026, 03:16 AMCached
AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.
Trademark Summary
The standard character mark QITOLBY covers pharmaceutical preparations in class 005 for the treatment of Parkinson's disease, cardiovascular diseases, inflammation, and cancer, with domestic classifications also in classes 006, 018, 044, 046, 051, and 052. It is registered on the Principal Register (registration number 8083447) effective December 30, 2025. Bayer Aktiengesellschaft, a German aktiengesellschaft based in Leverkusen, is the owner.
Recent Activity
Filed on February 27, 2025, the application was published for opposition on June 10, 2025, following an examiner's amendment on May 8, 2025. A Notice of Allowance issued on October 7, 2025, but the intent-to-use basis was deleted on October 13, 2025, allowing it to proceed directly to registration on December 30, 2025.
USPTO
AI Analysis
v2.8.0
Never miss important updates for this trademark
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach